Clinical Trial Update: Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of OPC-1085EL ophthalmic solution in glaucoma or ocular hypertension has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• OPC-1085EL ophthalmic solution (OPC-1085EL)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2015-11-17